IFCC Feed2021-09-20T03:12:19Z Insoft Feed Generator /ifcc-news/ IFCC eNews No 9 September 20212021-09-17T14:41:36Z /ifcc-news/2021-09-17-ifcc-enews-no-9-sep-2021/ IFCC Office  

IFCC eNews: September 2021

eNews logo large globe
Full PDF version

IN THIS ISSUE:

  • EDITORIAL
    • Message from the eNews Editor
  • THE VOICE OF IFCC 
    • IFCC President's message – September 2021
    • Published resources on clinical laboratory ethics & the new IFCC Code of Ethics
    • IFCC Townhalls 2021
  •  IFCC: THE PEOPLE
    • In memoriam: Vale Ian Goodall
  •  IFCC: THE YOUNG SCIENTISTS
    • IFCC Professional Scientific Exchange Programme (PSEP)
  • CONTRIBUTE TO THE IFCC eNEWS
    • The unbearable summer with Delta
    • Strategic SARS-CoV-2 testing for risk mitigation and optimal healthcare workers and patients
    • Enhanced identification and care for patients with undetected HCV and/or HIV via Opt-Out ED screening with active education and linkage to care
    • Using data, innovation and collaboration to support better patient outcomes during the COVID-19 pandemic
    • Recognizing additional advocates of the UNIVANTS of Healthcare Excellence Program
    • 10 Tips for success for UNIVANTS of Healthcare Excellence Awards
  • NEWS FROM REGIONAL FEDERATIONS AND MEMBER SOCIETIES
    • News from the Spanish Society of Laboratory Medicine (SEQCML): Second Inter-hospital Conference
    • XXV COLABIOCLI CONGRESS
    • Conclusions and recommendations of the Conference Reframe Rare in Pakistan: 'Bringing Synergies and Breaking Silos'
    • Surfing on the wave of POCT innovations and m-Health in Biarritz
    • Updates on EFLM publications
  • IFCC WELCOMES A NEW MEMBER
    • GenScript Biotech Corporation
  • IFCC'S CALENDAR OF CONGRESSES, CONFERENCES & EVENTS
    • Calendar of IFCC Congresses/Conferences and Regional Federations' Congresses
    • Other events with IFCC auspices
]]>
The IFCC Townhall for AFCB, AFCC and EFLM is already available!2021-09-15T14:48:08Z /ifcc-news/2021-09-15-the-ifcc-townhall-for-afcb-afcc-and-eflm-is-already-available/ IFCC Office

The AFCB, AFCC EFLM Townhall is a unique opportunity to bring everyone together in these regions and allow for exchange of ideas and free communication between various organizations.

September 15th, 2021
09.00 am -12.00 pm 
Central Europe time zone 
(Rome, Cape Town)

click here to watch it on demand

Members of AFCB, AFCC and EFLM Regional Federations and National Societies  interested in participating in this open communication forum to significantly enhance communication within our laboratory medicine community had the possibility to attend and could ask question in the Discussion Forum via chat.

Format: brief presentations by IFCC EB together with Executive Boards of AFCB, AFCC, EFLM Regional Federations followed by a Discussion Forum.

  • Prof. Khosrow Adeli – IFCC President
  • Dr. David Kinniburgh – IFCC Secretary
  • Dr. Alexander Haliassos – IFCC Treasurer
  • Mr. Joe Passarelli – IFCC Corporate Representative
  • Dr. Osama Najjiar – AFCB President
  • Prof. Rajiv Erasmus – AFCC President
  • Prof. Ana-Maria Šimundić – EFLM President

gave brief presentations to update the membership on current and upcoming IFCC programmes and new initiatives globally or in specific regions.

Don't miss this opportunity!

Two other Townhalls are planned in October for the Americas (NAFCC and COLABIOCLI) as well as Asia-Pacific (APFCB), in their own time zones.

]]>
IFCC Webinar on 8 September: Evidence-based Laboratory Medicine: the on demand content is available2021-09-13T13:05:01Z /ifcc-news/2021-09-09-ifcc-live-webinar-evidence-based-laboratory-medicine-on-demand-content-available/ IFCC Office

8th September 2021
IFCC webinar

 

The  IFCC webinar on "Evidence-based Laboratory Medicine"  was held on 8 September 2021.

It has been stated that the laboratory assists in 60-70% of all clinical decisions, e.g. admission, discharge, and drug therapy. The goal of the laboratory is to provide information that is useful in clinical decision-making and to prevent cases where incorrect interpretation leads to poor patient outcomes.

Evidence-based medicine (EBM) has been described as the “conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”. It involves the integration of best research evidence with clinical expertise and patient values. Evidence-based laboratory medicine (EBLM) focuses on the evaluation and use of laboratory tests to improve patient outcomes. It assists clinical management by integrating the best available research evidence for the use of laboratory investigations with the physician’s clinical expertise and the needs, expectations, and concerns of patients. This leads to improved care and outcomes of individual patients and the effective use of healthcare resources. Evidence-based guidelines are developed using the best evidence to develop statements that guide decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare.

In this webinar, the speakers covered the basic concepts of EBLM and the “5A’s” involved in obtaining this evidence. Then they discussed how guidelines are implemented using the best available evidence. And finally, they looked at the evidence to see whether the point of care testing confers any advantage in clinical decision-making in different scenarios.

  • Introduction to EBLM (Dr. Seema Bhargava – India)
  • Guideline Implementation (Dr. Andrew Don-Wauchope – Canada)
  • Point of Care Testing and EBLM (Dr. Karina Rodríguez-Capote – Canada)

Chair: Prof. Annalise Zemlin (South Africa)

 

The recorded webinar is available here

Certificate of Participation: available for all registrants

The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital

 

 

    

]]>
2021 09 02 EUROMEDLAB Munich 2021 Abstract submission postponed2021-09-02T09:47:43Z /ifcc-news/2021-09-02-euromedlab-munich-2021-abstract-submission/ IFCC Office

Deadline for receipt: 5th September 2021, 18:30 CET.

Click here to submit

Receipt of the abstract will be acknowledged by e-mail immediately after submission.

Authors will be notified of acceptance or rejection before 1st October 2021.

The presenting author of each abstract must register for the congress with “Full Registration”.

Abstracts are welcome in all fields of clinical chemistry, hematology, clinical molecular biology, and laboratory medicine, in the broader sense. Free communications are primarily presented via poster. A limited number of abstracts will be selected for oral presentation during symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the online abstract submission form.

 

 

]]>
Register to the IFCC Webinar on 8 September: Evidence-based Laboratory Medicine2021-09-02T06:29:24Z /ifcc-news/2021-09-01-register-to-the-ifcc-live-webinar-evidence-based-laboratory-medicine/ IFCC Office

8th September 2021
Don't miss the next IFCC webinar!

Registration is complimentary!

Click here to register

 

Dear Colleagues,

The next IFCC webinar "Evidence-based Laboratory Medicine"  will be held on 8 September 2021.

It has been stated that the laboratory assists in 60-70% of all clinical decisions, e.g. admission, discharge, and drug therapy. The goal of the laboratory is to provide information that is useful in clinical decision-making and to prevent cases where incorrect interpretation leads to poor patient outcomes.

Evidence-based medicine (EBM) has been described as the “conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”. It involves the integration of best research evidence with clinical expertise and patient values. Evidence-based laboratory medicine (EBLM) focuses on the evaluation and use of laboratory tests to improve patient outcomes. It assists clinical management by integrating the best available research evidence for the use of laboratory investigations with the physician’s clinical expertise and the needs, expectations, and concerns of patients. This leads to improved care and outcomes of individual patients and the effective use of healthcare resources. Evidence-based guidelines are developed using the best evidence to develop statements that guide decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare.

In this webinar, we will cover the basic concepts of EBLM and the “5A’s” involved in obtaining this evidence. Then we will discuss how guidelines are implemented using the best available evidence. And finally, we will look at the evidence to see whether the point of care testing confers any advantage in clinical decision-making in different scenarios.

  • Introduction to EBLM (Dr. Seema Bhargava – India)
  • Guideline Implementation (Dr. Andrew Don-Wauchope – Canada)
  • Point of Care Testing and EBLM (Dr. Katrina Rodríguez-Capote – Canada)

Chair: Prof. Annelise Zemlin (South Africa)

Please feel free to share this event on your social media with #IFCCwebinar

  • Schedule: 20 min per speaker plus 20 min panel discussion
  • Time Zones for 8 September: Live presentations starting at: 10:00AM EDT - 11:00AM Buenos Aires- AR; 4:00PM European Time; 7:30PM India; 10:00PM CST-Beijing
    Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. Click here to convert to your time zone.

Recorded webinar: available on demand

Certificate of Participation: available for all registrants

The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital

 

 

    

]]>
2021 08 30 EUROMEDLAB Munich 2021 Abstract submission expires tomorrow2021-08-31T09:38:14Z /ifcc-news/2021-08-30-euromedlab-munich-2021-abstract-submission/ IFCC Office

Deadline for receipt: 31st August 2021, 18:30 CET.

Click here to submit

Receipt of the abstract will be acknowledged by e-mail immediately after submission.

Authors will be notified of acceptance or rejection before 1st October 2021.

The presenting author of each abstract must register for the congress with “Full Registration”.

Abstracts are welcome in all fields of clinical chemistry, hematology, clinical molecular biology, and laboratory medicine, in the broader sense. Free communications are primarily presented via poster. A limited number of abstracts will be selected for oral presentation during symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the online abstract submission form.

 

 

]]>
Register to the IFCC Webinar on 31st August: Metrology and Clinical Laboratory2021-08-29T07:17:34Z /ifcc-news/2021-08-27-register-to-the-ifcc-live-webinar/ IFCC Office

31th August 2021
Don't miss next IFCC webinar!

Registration is complimentary!

Click here to register

 

Dear Colleagues,

The next IFCC webinar "Metrology and Clinical Laboratory"  will be held on 31 Aug, 2021.

Metrology is the science of measurements and their applications. It deals with the measurements, systems of units and instruments used to make them. Based on the data obtained from the measurements, decisions are taken. That is why it is very important that these data are reliable, reproducible and comparable between laboratories. The aim of metrology is to define and materialize the units of measurement and establish the traceability chain.

 

  • Schedule: 20 min per speaker plus 20 min panel discussion
  • Time Zones: Live presentations starting at: 10:00AM EDT - 11:00AM Buenos Aires- AR; 4:00PM European Time; 7:30PM India; 10:00PM CST-Beijing
    Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. Click here to convert to your time-zone. 

Recorded webinar: available on demand

Certificate of Participation: available for all registrants

 

The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital

 

 

    

]]>
IFCC Webinar on Lab 4.0: the on demand content is available now2021-09-09T11:02:12Z /ifcc-news/2021-08-26-ifcc-webinar-on-lab-40-the-on-demand-content-is-available-now/ IFCC Office The  IFCC webinar "Different Perspectives on Laboratory 4.0" was held on 24 Aug 2021.

The 4th Industrial revolution brought many innovations to the industry and business world and introduced new technologies to laboratories. Although automation and data analysis are familiar to clinical laboratories, it’s the reality that laboratories will face new challenges due to increasing innovative techniques and big data.

In this panel, the advantages & benefits, and risks of Laboratory 4.0 were discussed from the perspective of laboratory professionals, universities, and industry. This webinar contributed to understanding the impact of Industry 4.0 on clinical laboratory processes, the effect of innovative technical developments on laboratory-industry cooperation, and laboratory-patient-physician communication. During the webinar, the future-oriented training of lab professionals for lab 4.0 was discussed.


click here for the on demand content


Certificate of Participation: available for all registrants

]]>
Code of Ethics by the IFCC Task Force on Ethics2021-09-09T11:01:51Z /ifcc-news/2021-08-20-tf-e-code-of-ethics/ IFCC Office This Code of Ethics of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)" focuses on three targets of duty and it is structurally based on the principles delineated in the Belmont Report created in 1978 by the then U.S.A. National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research; its principles also being equally valid for diagnostic medical laboratory work for humans, both then and now.

The "Code of Ethics of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)" is authored by the IFCC Taskforce on Ethics and it has been Reviewed & Approved by the IFCC Executive Board.

Click here to read the "IFCC Code of Ethics".

]]>
Scam messages2021-08-24T15:23:06Z /ifcc-news/2021-06-21-scam-messages/ IFCC Office The email messages (and websites) look official enough that they deceive many people into believing that they are legitimate. Believing that these emails are legitimate, unsuspecting people often respond to the email's requests for their credit card numbers, passwords, account information, or other personal information.

Never respond to requests for personal information via email. Legitimate organizations will never ask for passwords, credit card numbers, or other personal information in an email.  If you receive an email requesting this kind of information, DO NOT RESPOND, DO NOT REPLY, DO NOT CLICK ON LINKS OR IMAGES, and DO NOT OPEN ANY ATTACHMENTS with the message.  If you think the email is legitimate, contact the company through their official contacts to confirm. Updating your systems with good security software can help defend data, users, systems, and companies from a wide range of risks.

Remember that the IFCC never requests money or credit card numbers, passwords, account information, or other personal information.

]]>